In a survey completed by the European Society for Medical Oncology Young Oncologists Committee, 700 specialists provided real-world responses about the treatment of patients with lung cancer who have had their tumors incompletely resected.
Researcher found that certain chemotherapy regimens for breast cancer were associated with an increased risk for hospitalization.
Terminally ill cancer patients receiving chemotherapy at the end of life are at increased risk of dying in an ICU, according to a new study.
Recent studies have revealed disappointing results for gemcitabine—but more support for taxane-first sequencing.
Ipilimumab plus RT vs. RT alone increased median OS in patients with chemotherapy-naïve mCRPC and specific prognostic features.
Early outpatient management of low-risk febrile neutropenia with oral or IV antibiotics is emerging as a potential alternative to traditional prolonged IV-only therapy.
Adding carboplatin or bevacizumab to standard chemotherapy improves pCR in TNBC.
Discussions with patients about fertility preservation prior to their cancer treatments are critical.
Women with metastatic breast cancer who respond to chemotherapy should not receive locoregional treatment.
Free searchable drug-gene database, modeled on Google, may help researchers and clinicians develop novel therapies for cancer.
